Erythropoietin drives breast cancer progression by activation of its receptor EPOR
View/ Open
El-Tanani_et_al_Oncotarget.pdf (5.575Mb)
Download
Publication date
2017-03-18Author
Chan, K.K.Matchett, K.B.
Coulter, J.A.
Yuen, H-F.
McCrudden, C.M.
Zhang, S-D.
Irwin, G.W.
Davidson, M.A.
Rülicke, T.
Schober, S.
Hengst, L.
Jaekel, H.
Platt-Higgins, A.
Rudland, P.S.
Mills, K.I.
Maxwell, P.
El-Tanani, Mohamed
Lappin, T.R.
Rights
© 2017 Chan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Peer-Reviewed
Yes